TITLE

Angiotensin receptor blockers (ARBs)

AUTHOR(S)
Gellad, Walid F.; Good, C. Bernie
PUB. DATE
April 2011
SOURCE
CMAJ: Canadian Medical Association Journal;4/19/2011, Vol. 183 Issue 7, p826
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "The potential economic impact of restricted access to angiotensin-receptor blockers," by J. R. Guertin and colleagues in an issue in 2011.
ACCESSION #
61406925

 

Related Articles

  • Treating Prehypertension. Grassi, Daniel G. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p416 

    A letter to the editor is presented in response to the article "Feasibility of Treating Prehypertension With an Angiotensin-Receptor Blocker," by S. Julius, S. D. Nesbitt, B. M. Egan et al. in the April 20, 2006 issue.

  • Treating Prehypertension. Lopez-Plasencia, Yaiza; Amela-Peris, Raul // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p416 

    A letter to the editor is presented in response to the article "Feasibility of Treating Prehypertension With an Angiotensin-Receptor Blocker," by S. Julius, S. D. Nesbitt, B. M. Egan et al. in the April 20, 2006 issue.

  • Treating Prehypertension. Conen, David; Martina, Benedict // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p416 

    A letter to the editor is presented in response to the article "Feasibility of Treating Prehypertension With an Angiotensin-Receptor Blocker," by S. Julius, S. D. Nesbitt, B. M. Egan et al. in the April 20, 2006 issue.

  • Treating Prehypertension. Baumann, Marcus; Van den Born, Bert-Jan // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p416 

    A letter to the editor is presented in response to the article "Feasibility of Treating Prehypertension With an Angiotensin-Receptor Blocker," by S. Julius, S. D. Nesbitt, B. M. Egan et al. in the April 20, 2006 issue.

  • Treating Prehypertension. Julius, Stevo; Nesbitt, Shawna D.; Egan, Brent M. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p416 

    A letter to the editor is presented in response to the article "Feasibility of Treating Prehypertension With an Angiotensin-Receptor Blocker," by S. Julius, S. D. Nesbitt, B. M. Egan et al. in the April 20, 2006 issue.

  • Valsartan in Chronic Heart Failure. Haddy, Francis J. // New England Journal of Medicine;4/11/2002, Vol. 346 Issue 15, p1173 

    A letter to the editor is presented in response to a study on angiotensin-receptor blocker valsartan in chronic heart failure by researchers Jay N. Cohn and Gianni Tognoni in the December 6, 2001 issue.

  • Valsartan in Chronic Heart Failure. Cayley, William E. // New England Journal of Medicine;4/11/2002, Vol. 346 Issue 15, p1173 

    A letter to the editor is presented in response to a study on angiotensin-receptor blocker valsartan in chronic heart failure by researchers Jay N. Cohn and Gianni Tognoni in the December 6, 2001 issue.

  • Valsartan in Chronic Heart Failure. Cohn, Jay N.; Tognoni, Gianni // New England Journal of Medicine;4/11/2002, Vol. 346 Issue 15, p1173 

    A response by researchers Jay N. Cohn and Gianni Tognoni to several letters to the editor about their article on angiotensin-receptor blocker valsartan in chronic heart failure in the December 6, 2001 issue is presented.

  • Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection. Blankfield, Robert P. // New England Journal of Medicine;2/28/2002, Vol. 346 Issue 9, p705 

    A letter to the editor is presented in response to three separate studies on the renoprotective effects of angiotensin-receptor blockers in patients with type 2 diabetes, one by Edmund J. Lewis and colleagues, another by Barry M. Brenner and colleagues, and another by Hans-Henrik Parving and...

  • Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection. Walser, Mackenzie // New England Journal of Medicine;2/28/2002, Vol. 346 Issue 9, p705 

    A letter to the editor is presented in response to two separate studies on the renoprotective effects of angiotensin-receptor blockers in patients with type 2 diabetes, one by Barry M. Brenner and colleagues and another by Edmund J. Lewis and colleagues, in the September 20, 2001 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics